For nearly a decade, a baffling mystery has haunted American and Canadian government officials: a cluster of debilitating symptoms – intense headaches, crippling vertigo, and disorienting dizziness – first reported in Havana, Cuba. These “anomalous health episodes,” as they became known, left sufferers grappling with insomnia and alarming cognitive difficulties.
Now, a potential explanation may be emerging from within the U.S. government itself. Investigators, operating under the Department of Homeland Security, reportedly secured a mysterious device in a covert operation, an acquisition that cost millions.
The device, small enough to fit inside a backpack, is currently undergoing rigorous testing by the Department of Defense. While its origins aren’t entirely clear, components traced back to Russia have fueled speculation about its purpose and connection to the health crisis.
Early reports suggest the device emits pulsed radio waves – a detail that resonates with previous theories positing directed energy as a potential cause of the symptoms. The acquisition occurred in the final days of a recent administration, with officials authorizing an “eight-figure” payment for the technology.
The initial outbreak of symptoms began in late 2016, with U.S. and Canadian personnel in Havana describing a strange, piercing sound accompanied by a sensation of pressure in the head. These sensations often preceded the onset of the neurological issues.
Numerous theories circulated, ranging from the possibility of sophisticated directed-energy weapons to exposure to unknown neurotoxins, and even collective psychological factors. However, medical experts remained stumped, unable to pinpoint a definitive cause.
A 2023 assessment by the U.S. National Intelligence Council offered a cautious conclusion, deeming it “very unlikely” that a foreign adversary had deployed an energy weapon to deliberately cause the illnesses. This assessment, however, didn’t entirely dismiss the possibility.
Researchers at the National Institutes of Health conducted extensive brain scans – magnetic resonance imaging (MRI) – on 81 individuals who reported experiencing these anomalous health incidents. The scans were performed relatively quickly after symptom onset, with an average timeframe of 80 days.
Surprisingly, the MRI results revealed no significant differences in the brains of those affected compared to a control group. Published in March 2024, the findings suggested that while an initial event may have triggered the symptoms, it didn’t appear to cause lasting neurological damage.
Lead researcher Carlo Pierpaoli emphasized that the absence of long-term neuroimaging changes offered a degree of reassurance, suggesting the condition wasn’t linked to severe neurodegenerative processes. The mystery, however, remains far from fully resolved, and the investigation into the device continues.
